Mineralys Therapeutics
MLYS
#5632
Rank
$1.40 B
Marketcap
$15.83
Share price
-2.04%
Change (1 day)
-66.40%
Change (1 year)

Mineralys Therapeutics (MLYS) - Total debt

Total debt on the balance sheet as of June 2026 : N/A

According to Mineralys Therapeutics's latest financial reports the company's total debt is N/A. A companyโ€™s total debt is the sum of all current and non-current debts.

Mineralys Therapeutics - Total debt on balance sheet (in 2020)

Total debt by year

Year Total debt Change
2020-12-31$4.5 M